231 related articles for article (PubMed ID: 2562523)
1. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.
Augsburger JJ; Gamel JW; Shields JA
Trans Am Ophthalmol Soc; 1989; 87():348-59; discussion 359-61. PubMed ID: 2562523
[No Abstract] [Full Text] [Related]
2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
3. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
7. [Plaque radiotherapy of uveal malignant melanoma has redeemed its promise].
Kivelä T
Duodecim; 1995; 111(16):1521-2. PubMed ID: 9273259
[No Abstract] [Full Text] [Related]
8. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
9. A comparison of prognostic covariates for uveal melanoma.
Gamel JW; McCurdy JB; McLean IW
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
[TBL] [Abstract][Full Text] [Related]
10. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
12. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
Augsburger JJ; Schneider S; Freire J; Brady LW
Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of posterior uveal melanoma.
Zhao DY; Shields CL; Shields JA; Gunduz K
J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
[TBL] [Abstract][Full Text] [Related]
14. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
15. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
16. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS
Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
[TBL] [Abstract][Full Text] [Related]
17. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy.
Karlsson UL; Augsburger JJ; Shields JA; Markoe AM; Brady LW; Woodleigh R
Ophthalmology; 1989 Mar; 96(3):382-8. PubMed ID: 2710530
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for uveal malignant melanoma.
Shields CL; Shields JA; Gündüz K; Freire JE; Mercado G
Ophthalmic Surg Lasers; 1998 May; 29(5):397-409. PubMed ID: 9599365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
